search
Back to results

Support Via Technology: Living and Learning With Advancing FTD (STELLA-FTD)

Primary Purpose

Caregivers Burnout, Frontotemporal Dementia

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
STELLA-FTD
Sponsored by
Oregon Health and Science University
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an interventional treatment trial for Caregivers Burnout

Eligibility Criteria

18 Years - 100 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Care Partner for family member, close friend or kin with FTD, primary progressive aphasia, progressive supranuclear palsy or other frontotemporal degenerative dementia
  • Must speak English
  • Must be able to see and hear the videoconference-based interactions.

Exclusion Criteria:

- Family member does not care for someone with FTD conditions.

Sites / Locations

  • Oregon Health and Science University, Layton Aging and Alzheimer's Disease Center

Outcomes

Primary Outcome Measures

Revised Memory and Behavior Problems Checklist (change is being assessed) Behavior Problems Checklist
Assesses burden, stress: Higher scores on frequency indicate more upsetting behaviors, higher scores on reactivity indicate more caregiver burden

Secondary Outcome Measures

Quality of life, care partners and care recipients (change is being assessed)
Measures sense of quality of life for Care Partner; 13 items, higher scores suggest better quality of life
Quality of life, care partners and care recipients (change is being assessed)
Measures sense of quality of life for person with dementia (filled out by proxy caregiver): 13 items, higher scores suggest better quality of life
Family Caregiver Self efficacy scale (change is being assessed)
measures caregiver self efficacy for symptoms management and community support service use. Scale 10-100, higher scores indicating better sense of self-efficacy
Center for Epidemiologic Studies Depression-10-item scale (change is being assessed); score is 0 (no depression) to 30 (severe depression).
Depression in caregivers
Marwit Meuser Caregiver Grief Index (change is being assessed)
Caregiver grief; Scale 18-90, higher scores=worse grief
Caregiver Guilt Questionnaire (change is being assessed)
Caregiver guilt; score range 22-88, higher scores=worse guilt
Contact survey
How often do caregivers contact each other?
Experience Survey
Caregiver assessment of program
Ten-item personality inventory
Measures extra/introversion (provides information about introversion/extraversion, no "good" or "bad" scores

Full Information

First Posted
March 4, 2022
Last Updated
April 18, 2022
Sponsor
Oregon Health and Science University
Collaborators
Association for Frontotemporal Degeneration
search

1. Study Identification

Unique Protocol Identification Number
NCT05338710
Brief Title
Support Via Technology: Living and Learning With Advancing FTD
Acronym
STELLA-FTD
Official Title
Support Via Technology: Living and Learning With Advancing FTD
Study Type
Interventional

2. Study Status

Record Verification Date
April 2022
Overall Recruitment Status
Completed
Study Start Date
January 14, 2021 (Actual)
Primary Completion Date
March 4, 2022 (Actual)
Study Completion Date
March 4, 2022 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Oregon Health and Science University
Collaborators
Association for Frontotemporal Degeneration

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Much effort over the last several decades has been devoted to developing and implementing psychoeducational interventions for family caregiving partners for those with Alzheimer's and relatedm dementias (ADRD). However, few interventions address the specific needs of care partners for those with frontotemporal degeneration (FTD). This study tests an intervention to support family caregivers for those with FTD.
Detailed Description
Much effort over the last several decades has been devoted to developing and implementing psychoeducational interventions for family caregiving partners for those with Alzheimer's and related dementias (ADRD). However, few interventions address the specific needs of care partners for those with frontotemporal degeneration (FTD), the most common form of dementia in adults under age 60. Caring for a family member with FTD can affect the psychological, social, and relational health of families. Care partners for those with the disease have higher levels of burden and depression, as well as more sleep disturbances and worse financial strain than care partners for those with ADRD. Psychoeducational interventions can alleviate some of the psychological symptoms associated with dementia caregiving, but few programs have been designed for care partners for persons with FTD. Further, many of the existing programs are inaccessible for families due to distance and cost. The STELLA (Support via TEchnology: Living and Learning with Advancing dementia) intervention is designed to teach ADRD care partners strategies for managing behavioral symptoms associated with dementia. STELLA uses videoconferencing to connect care partners, in their own homes, with experienced Guides (e.g., nurses). The Guides use cognitive behavioral techniques to assist care partners in identifying and implementing strategies to reduce distressing behavioral symptoms in the person with dementia. Our pilot work found that early versions of STELLA reduced the frequency of behavioral symptoms and care partner reactivity to them. In this study, the investigators will adapt STELLA to specifically address the needs of family care partners for persons with frontotemporal degeneration. Aim 1. Adapt STELLA to the needs of care partners for those with FTD Gather FTD care partner feedback on STELLA and suggestions for tailoring STELLA for FTD Adapt STELLA for FTD care partners based on end-user feedback Aim 2. Assess the feasibility, acceptability and STELLA-FTD with FTD care partners Aim 3. Assess the preliminary efficacy of STELLA-FTD on the primary outcomes: reducing the frequency of behavioral symptoms and care partner reactivity to the symptoms as measured on the Revised Memory and Behavior Problems Checklist (RMBPC).

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Caregivers Burnout, Frontotemporal Dementia

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Model Description
8-week single group intervention
Masking
None (Open Label)
Allocation
N/A
Enrollment
16 (Actual)

8. Arms, Groups, and Interventions

Intervention Type
Other
Intervention Name(s)
STELLA-FTD
Intervention Description
Behavioral intervention for caregivers for those with FTD
Primary Outcome Measure Information:
Title
Revised Memory and Behavior Problems Checklist (change is being assessed) Behavior Problems Checklist
Description
Assesses burden, stress: Higher scores on frequency indicate more upsetting behaviors, higher scores on reactivity indicate more caregiver burden
Time Frame
Weeks 1 and 9 of study
Secondary Outcome Measure Information:
Title
Quality of life, care partners and care recipients (change is being assessed)
Description
Measures sense of quality of life for Care Partner; 13 items, higher scores suggest better quality of life
Time Frame
Weeks 1 and 9 of study
Title
Quality of life, care partners and care recipients (change is being assessed)
Description
Measures sense of quality of life for person with dementia (filled out by proxy caregiver): 13 items, higher scores suggest better quality of life
Time Frame
Weeks 1 and 9 of study
Title
Family Caregiver Self efficacy scale (change is being assessed)
Description
measures caregiver self efficacy for symptoms management and community support service use. Scale 10-100, higher scores indicating better sense of self-efficacy
Time Frame
Weeks 1 and 9 of study
Title
Center for Epidemiologic Studies Depression-10-item scale (change is being assessed); score is 0 (no depression) to 30 (severe depression).
Description
Depression in caregivers
Time Frame
Weeks 1 and 9 of study
Title
Marwit Meuser Caregiver Grief Index (change is being assessed)
Description
Caregiver grief; Scale 18-90, higher scores=worse grief
Time Frame
Weeks 1 and 9 of study
Title
Caregiver Guilt Questionnaire (change is being assessed)
Description
Caregiver guilt; score range 22-88, higher scores=worse guilt
Time Frame
Weeks 1 and 9 of study
Title
Contact survey
Description
How often do caregivers contact each other?
Time Frame
9 weeks after study start
Title
Experience Survey
Description
Caregiver assessment of program
Time Frame
9 weeks after study start
Title
Ten-item personality inventory
Description
Measures extra/introversion (provides information about introversion/extraversion, no "good" or "bad" scores
Time Frame
Week 1 of study

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
100 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Care Partner for family member, close friend or kin with FTD, primary progressive aphasia, progressive supranuclear palsy or other frontotemporal degenerative dementia Must speak English Must be able to see and hear the videoconference-based interactions. Exclusion Criteria: - Family member does not care for someone with FTD conditions.
Facility Information:
Facility Name
Oregon Health and Science University, Layton Aging and Alzheimer's Disease Center
City
Portland
State/Province
Oregon
ZIP/Postal Code
97239
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
Undecided
IPD Sharing Plan Description
Video-recordings and other data from this study may be shared with other investigators for future research studies. A study ID number will be assigned to each participant. Only the investigators and people involved in the conduct of the study will be authorized to link the ID number to the participants. Other investigators who may receive samples of data for research will be given only the ID number which will not identify participants. However, the video-recordings will show participants' faces. Names and any information discussed during the sessions and focus group will be heard in the audio. The faces, names and audio of any other people who enter the camera zone will also be recorded. The information given for this study will be identifiable and will not be private. Participants receive this information on the information sheet.

Learn more about this trial

Support Via Technology: Living and Learning With Advancing FTD

We'll reach out to this number within 24 hrs